Afton Scientific has begun construction on a $200 million expansion of its facility in Albemarle County, Virginia. The project, supported by state leadership, is expected to create at least 200 jobs and increase the site’s footprint by eight times its
Symbiosis Pharmaceutical Services has completed the qualification of its new FPD 50 Flexicon automated fill/finish line at its commercial production facility in Stirling, Scotland. The fully integrated system, operating under a Grade A Restricted Access Barrier System (RABS), is designed
FAMAR has announced a leadership transition as Konstantinos Rengis steps down as CEO for personal reasons, effective September 29, 2025. Rengis has been with the company for 16 years, serving as CEO for the past four. During his tenure, he
Locus Cell, a regenerative medicine CDMO in Taiwan, has entered a Memorandum of Understanding (MOU) with Australia-based Cambium Bio to provide contract development and manufacturing for Elate Ocular®. The therapy, currently in Phase III clinical trials, targets dry eye disease
AbbVie has announced the groundbreaking of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago, Illinois. The facility is part of the company’s broader strategy to expand its U.S. manufacturing capabilities and network. The new site will enhance
President Donald Trump announced on September 26 that brand-name and patented pharmaceutical products will face a 100% tariff beginning October 1, unless drugmakers are actively constructing manufacturing facilities in the United States. The sweeping tariff policy represents the administration’s most
The Swiss-based parent company will retain the Polpharma Biologics brand and continue its biosimilars business. Meanwhile, Rezon Bio will operate CDMO services from two facilities in Poland – located in Gdańsk and Duchnice near Warsaw. Proven Infrastructure and Regulatory Standing
PolyPeptide has announced a capacity expansion at its Braine-l’Alleud facility in Belgium. The investment, backed by customer financing, is aimed at strengthening its role in the growing global peptide market. The upgrade will include advanced process equipment designed for complex
Master the strategic process that transforms CDMO partnerships from risky transactions into competitive advantages
Amgen has announced a $650 million expansion of its US manufacturing network, creating nearly 750 new jobs at its biologics manufacturing facility in Juncos, Puerto Rico. The investment will support increased drug production and integrate advanced technologies throughout the operations
